Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/1995
10/12/1995WO1995026966A1 Cephalosporin antibiotics
10/12/1995WO1995026965A1 Improved process for making a d-(+)-biotine intermediate product
10/12/1995WO1995026963A1 Stable aqueous folinate solution
10/12/1995WO1995026962A1 Thiazolylpyrazolinones and their use for protecting technical materials
10/12/1995WO1995026960A1 Physiologically active substance ei-1507
10/12/1995WO1995026958A1 Pyrimidinyl derivatives as interleukin inhibitors
10/12/1995WO1995026957A1 N-heterocyclyl sulphonamide derivatives and their use as endothelin antagonists
10/12/1995WO1995026794A1 Solvent extraction process
10/12/1995WO1995026768A1 Methods for treating pulmonary vasoconstriction and asthma
10/12/1995WO1995026746A1 Compositions and methods for stimulating megakaryocyte growth and differentiation
10/12/1995WO1995026743A1 Nadh oxidase as a target in diagnosis and therapy
10/12/1995WO1995026739A2 Use of substituted dextranes for treating nervous system damage, and heparane sulphate-enriched fractions
10/12/1995WO1995026738A1 Use of growth factor protecting polymers for treating inflammation
10/12/1995WO1995026737A1 Use of biopolymers for digestive tract injuries treatment
10/12/1995WO1995026736A1 Use of biopolymers for the muscle treatment
10/12/1995WO1995026735A1 Use of intratracheally administered hyaluronic acid to ameliorate emphysema
10/12/1995WO1995026734A1 Use of phosphonylmethoxyalkyl nucleosides for the treatment of raised intraocular pressure
10/12/1995WO1995026731A1 Treating cardiovascular disease with steroidal 5-alpha-reductase inhibitors
10/12/1995WO1995026730A1 Combined hormonal contraception pharmaceutical preparation
10/12/1995WO1995026729A1 New prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
10/12/1995WO1995026728A1 Prevention and treatment of ischemia-reperfusion and endotoxin-related injury using adenosine and purino receptor antagonists
10/12/1995WO1995026727A1 Use of xanthine derivatives for reducing the pathological hyper-reactivity of eosinophilic granulocytes, novel xanthine compounds and process for producing them
10/12/1995WO1995026726A1 Pharmaceutical composition containing a class iii antiarrhythmic agent and a class iv antiarrhythmic agent
10/12/1995WO1995026725A1 Pharmaceutical preparations and medicaments for the prevention and treatment of endothelial dysfunction
10/12/1995WO1995026724A1 Improvement of insulin sensitivity with angiotensin ii receptor blocking imidazoles
10/12/1995WO1995026723A1 Novel substituted tryptamines, phenalkylamines and related compounds
10/12/1995WO1995026722A1 Method for inhibiting mast cell and basophil activation
10/12/1995WO1995026721A1 Inhibiting vascular smooth muscle cell proliferation
10/12/1995WO1995026720A1 Permanently ionic derivatives of steroid hormones and their antagonists
10/12/1995WO1995026717A1 Use of estrone derivatives as steroid sulphatase inhibitors
10/12/1995WO1995026716A1 Pyrimidine or triazine carboxylic acid derivatives to be used as medicaments
10/12/1995WO1995026713A1 Heterofunctional, mucoadhesive dosage form
10/12/1995WO1995026712A1 Ophthalmic composition containing an ion sensitive, hydrophilic polymer and an inorganic salt in a ratio which gives low viscosity
10/12/1995WO1995026711A1 Ophthalmic composition with decreased viscosity
10/12/1995WO1995026709A1 Topical retinal-based composition
10/12/1995WO1995026632A1 METHODS FOR USE OF GABAA RECEPTOR GABAergic COMPOUNDS
10/12/1995WO1995025509A3 Use of n-acyl derivatives of aminoalcohols in the manufacture of a medicament for practising neuroprotective action in neuropathological states connected with excitotoxicity
10/12/1995WO1995025091A3 Nipecotic acid derivatives as antithrombic compounds
10/12/1995DE4411956A1 Agents for influencing hyperactive immunological effector cells
10/12/1995DE4411660A1 Verwendung von Xanthinderivaten zur Reduktion der pathologischen Hyperreagibilität eosinophiler Granulozyten, neue Xanthinverbindungen und Verfahren zu deren Herstellung The use of xanthine derivatives for reducing the pathological hyperreactivity eosinophilic granulocytes, new xanthine compounds and processes for their preparation
10/12/1995CA2563203A1 Prevention and treatment of ischemia-reperfusion and endotoxin-related injury using adenosine and purino receptor antagonists
10/12/1995CA2187200A1 Nadh oxidase as a target in diagnosis and therapy
10/12/1995CA2187193A1 Cytotoxic t-cell lymphocyte ("ctl") activity regulation by class i mhc peptides
10/12/1995CA2187166A1 Novel substituted tryptamines, phenalkylamines and related compounds
10/12/1995CA2187081A1 Use of xanthine derivatives for reducing the pathological hyper-reactivity of eosinophilic granulocytes, novel xanthine compounds and process for producing them
10/12/1995CA2186908A1 .alpha.-1-antichymotrypsin analogues having elastase inhibitory activity
10/12/1995CA2186894A1 Cephalosporin antibiotics
10/12/1995CA2186863A1 Heterofunctional, mucoadhesive dosage form
10/12/1995CA2186859A1 Molecular cloning and expression of a .gamma.-interferon inducible activator of the proteasome
10/12/1995CA2186783A1 Pharmaceutical preparations and medicinal substances for the prevention and treatment of endothelial dysfunctions
10/12/1995CA2186758A1 Use of growth factor protecting polymers for treating inflammation
10/12/1995CA2186739A1 Combined hormonal contraception pharmaceutical preparation
10/12/1995CA2186734A1 Ophthalmic composition with decreased viscosity
10/12/1995CA2186636A1 Diagnosis, therapy and cellular and animal models for diseases associated with mitochondrial defects
10/12/1995CA2186604A1 Permanently ionic derivatives of steroid hormones and their antagonists
10/12/1995CA2186591A1 Ophthalmic composition containing an ion sensitive, hydrophilic polymer and an inorganic salt in a ratio which gives low viscosity
10/12/1995CA2186250A1 Modified oligonucleotides and intermediates useful in nucleic acid therapeutics
10/12/1995CA2186107A1 Use of dna oligomers for inhibition of hiv by decreasing ribosomal frameshifting
10/12/1995CA2185699A1 Use of phosphonylmethoxyalkyl nucleosides for the treatment of raised intraocular pressure
10/12/1995CA2185422A1 Solvent extraction process
10/12/1995CA2184261A1 Alphavirus cdna vectors
10/12/1995CA2182700A1 Screening method using the rzr receptor family
10/12/1995CA2146701A1 Heterocyclic compounds having anti-diabetic activity, their preparation and their use
10/12/1995CA2120967A1 Medicine for the treatment of psoriasis and skin diseases
10/11/1995EP0676471A2 Effector proteins of rapamycin
10/11/1995EP0676409A1 Erythromycin derivatives, their process for preparation and their application as medicaments
10/11/1995EP0676398A2 Heterocyclic compounds having anti-diabetic activity, their preparation and their use
10/11/1995EP0676396A1 Tetrazolylphenyl pivalate derivatives and medicinal composition containing the same as effective component
10/11/1995EP0676395A2 Substituted N-heteroaroylguanidines, as inhibitors of sodium-hydrogen exchange, as antiarrhythmic agents and as inhibitors of the proliferation of cells
10/11/1995EP0676207A2 Anticomplementary agent prepared from fucans of brown seaweed
10/11/1995EP0676206A1 Antimalarial
10/11/1995EP0676205A1 Cerebral metabolism activator containing glucose ester derivative
10/11/1995EP0676204A1 Combinations of an organic nitrate and a salicylate
10/11/1995EP0676203A1 Pharmaceutical compositions of antiglucocorticoid compounds for treating or preventing symptoms of spontaneous or narcotic-induced withdrawal
10/11/1995EP0676202A2 Use of aromatic steroids substituted in 3-position by a disubstituted aminoalkoxy chain for the manufacture of a medicament for the control of fertility, in particular male fertility
10/11/1995EP0676201A2 Use of a riminophenazine for treating MDR resistance
10/11/1995EP0676200A2 Use of eliprodil and of its enantiomers in the preparation of medicaments for the treatment of peripheral neuropathies and or central neurodegenerative diseases
10/11/1995EP0676199A1 Use of trovafloxacin or derivatives thereof for the manufacture of a medicament for the treatment of H. pylori infections
10/11/1995EP0676198A1 Fungicidal compositions containing a combination of bifonazole and fluocinonide
10/11/1995EP0676197A2 Gamma-linolenic acid for the preparation of a medicament for prevention reocclution of arteries
10/11/1995EP0676194A2 Cosmetic or dermatological compositions comprising an alpha-hydroxy acid, salicylic acid and a retinoid
10/11/1995EP0676190A2 Composition effective against foot odour containing monoglycerolesters of fatty acids
10/11/1995EP0676187A2 Composition containing a non photocatalytic metal oxide and tocopherol, its cosmetic and/or dermatologic use and methods for its preparation
10/11/1995EP0675961A1 Methods and compositions for gene, tumor, and viral infection therapy, and prevention of programmed cell death (apoptosis)
10/11/1995EP0675955A1 Molecular flashlight
10/11/1995EP0675896A1 Purine derivatives
10/11/1995EP0675895A1 Etoposide derivatives, process for their preparation, their use as a drug and in the preparation of a drug for treating cancer.
10/11/1995EP0675893A1 Anticonvulsant sorbopyranose sulfamates
10/11/1995EP0675892A1 Novel phosphorus-containing spin-trap compositions
10/11/1995EP0675889A1 Antiallergic triazolo(pyrrolo, thieno or furano)azepine derivatives
10/11/1995EP0675888A1 Sesquiterpenes, their preparation and their use as inhibitors acting on the gaba-benzodiazepine receptor
10/11/1995EP0675887A1 Antiallergic triazolobenzazepine derivatives
10/11/1995EP0675886A1 Aminomethylene substituted non-aromatic heterocycles and use as substance p antagonists
10/11/1995EP0675883A1 Piperidine derivatives as calcium channel antagonists
10/11/1995EP0675882A1 5-aryl-1,3-thiazine derivatives, manufacture thereof and use as pesticides
10/11/1995EP0675881A1 Use of benzotriazines as pla 2? inhibitors, and new benzotriazines.
10/11/1995EP0675733A1 Peptide-carbohydrate conjugates generating t-cell immunity
10/11/1995EP0675730A1 Therapeutic combination containing interferon
10/11/1995EP0675723A1 Bisphosphonate/estrogen therapy for treating and preventing bone loss
10/11/1995EP0675722A1 Hydroxy vitamin d3 compounds for treating skin atrophy
1 ... 6976 6977 6978 6979 6980 6981 6982 6983 6984 6985 6986 6987 6988 6989 6990 6991 6992 6993 6994 6995 6996 ... 7860